Ad is loading...
MENU
INMB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

INmune Bio (INMB) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

INMB is expected to report earnings to fall 8.15% to -55 cents per share on February 27

INmune Bio INMB Stock Earnings Reports
Q4'24
Est.
$-0.55
Q3'24
Missed
by $0.08
Q2'24
Beat
by $0.13
Q1'24
Missed
by $0.08
Q4'23
Missed
by $0.04
The last earnings report on October 31 showed earnings per share of -60 cents, missing the estimate of -51 cents. With 195.22K shares outstanding, the current market capitalization sits at 111.97M.
View a ticker or compare two or three
INMB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapies that harness the patient's immune system to treat cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 NE Mizner Boulevard
Phone
+1 858 964-3720
Employees
17
Web
https://www.inmunebio.com